RELATED CONTENT
NEWS
- Rib-X inks potentially lucrative deal with Sanofi for new class of antibiotics
- VCs dump $67.5M into Rempex (rump Mpex) for ESKAPE efflux pump inhibitors
- IMI launches €224m R&D programme to tackle antibiotic resistance
- Sub-prime Rib-X chops offer price then postpones IPO as cash dwindles
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

